CapsoVision, Inc.

CV
$6.55 (- $0.02 - 0.30%)
Last updated: 2026-05-20 16:41 UTC
CV Metrics
Exchange
🇺🇸 NASDAQ XNCM
Nasdaq Capital MarketUnited StatesAmerica/New_York
SectorHealthcare
IndustryMedical Devices
ISINUS1409351079
CUSIP140935107
Market Price6.55
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyNone
P/E RatioN/A
EPS-0.48
Market Cap$672.0M
Book Value0.44
Price to Book32.826
Beta0.94
52w High15.37
52w Low3.43
Next Earnings DateN/A

CapsoVision, Inc. trades under ticker CV on NASDAQ as a stock. Use this page to review stock price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US1409351079, CUSIP 140935107.

About the Company
CapsoVision, Inc. is a commercial-stage medical technology company specializing in advanced imaging and artificial intelligence technologies for endoscopy solutions. It focuses on identifying abnormalities in the gastrointestinal tract for diagnostic and screening purposes. The company's core product is the CapsoCam Plus, a single-use capsule endoscope system that provides panoramic visualization of the small-bowel mucosa to detect conditions such as obscure gastrointestinal bleeding and Crohn's disease. Additional offerings include CapsoCam Colon for colon visualization, polyp detection, and measurement, along with CapsoCloud, a cloud-based software-as-a-service platform for video access and download; CapsoAccess for capsule data management; CapsoView for video reading; and CapsoRetrieve, a retrieval kit using a magnetic wand. CapsoVision also provides capsule video reading services. These solutions serve gastrointestinal medical practices, clinics, and hospitals through distributor customers who resell the products. Founded in 2005 and headquartered in Saratoga, California, CapsoVision plays a key role in enhancing non-invasive diagnostic capabilities within the health technology sector.
Price History